Skip to Content

CTT Pharmaceutical Holdings Inc CTTH

Morningstar Rating
$0.03 0.00 (16.40%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CTTH is trading at a 57% premium.
Price
$0.02
Fair Value
$7.16
Uncertainty
Extreme
1-Star Price
$6.43
5-Star Price
$2.60
Economic Moat
Tltw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CTTH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.03
Day Range
$0.020.03
52-Week Range
$0.000.10
Bid/Ask
$0.02 / $0.03
Market Cap
$1.41 Mil
Volume/Avg
27,150 / 24,601

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
2

Valuation

Metric
CTTH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CTTH

Financial Strength

Metric
CTTH
Quick Ratio
3.40
Current Ratio
3.40
Interest Coverage
Quick Ratio
CTTH

Profitability

Metric
CTTH
Return on Assets (Normalized)
−217.23%
Return on Equity (Normalized)
−741.62%
Return on Invested Capital (Normalized)
−741.62%
Return on Assets
CTTH
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRYrndqskstXnplknn$78.9 Bil
ZTS
Zoetis Inc Class ANzttttsxykHbk$77.6 Bil
HLN
Haleon PLC ADRVcfvvjsdDpbcs$37.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRKmhkmjgwFkwg$18.8 Bil
VTRS
Viatris IncDxwwhjbXvycv$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRBcqnpbzJzdx$11.8 Bil
CTLT
Catalent IncWhxxzwmHyxrc$9.9 Bil
PRGO
Perrigo Co PLCHmcpkrjsxDsryv$3.8 Bil
CURLF
Curaleaf Holdings IncKpnwmnpYnnf$3.4 Bil
PBH
Prestige Consumer Healthcare IncWckwnwpXzhlwhx$3.2 Bil

Sponsor Center